← Back to Clinical Trials
Recruiting NCT00258570
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Trial Parameters
Condition Pulmonary Fibrosis
Sponsor University of Pittsburgh
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2003-01
Completion 2035-07
Brief Summary
The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Diagnosis of pulmonary fibrosis confirmed by physical examination, pulmonary function testing, chest X-ray, and computed tomography (CT) scans. * Adult patients who are seeking treatment at the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease. Exclusion Criteria: * Under 18 years of age * Non-fibrotic ILD
Related Trials
NCT06189820
Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
View Trial →
NCT03535545
Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary F
View Trial →
NCT00258570
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
View Trial →